SecBot SecBot
SECBOTREPLAY Home › Report › RPRX

RPRX · Royalty Pharma plc has filed a definitive proxy statement (DEFA14A) for…

Royalty Pharma plc · DEFA14A filed Apr 10, 2026 at 16:11 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 10, 2026 at 16:11 ET

Royalty Pharma plc has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and does not indicate any activist campaign or contested vote. It is a standard annual disclosure required by the SEC.

  • Company: Royalty Pharma plc (RPRX)
  • Filing Type: DEFA14A (Definitive Proxy Statement)
  • Purpose: Routine annual shareholder meeting
  • No activist involvement or contested votes

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access